Physician

Amar Patel, MD

According to 2025 Medicare claims, Amar Patel, MD (NPI: 1871882449) practices ophthalmology in the Tyler, TX market, with the plurality of this provider's patient population coming from Smith, TX. This provider's primary affiliated billing organization is HARSHI BAINS MDPA (NPI: 1275644049; TIN: 200937057) and primary practice location at 75703-6124.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,852 traditional Medicare patients, billed 49,467 HCPCS/CPT codes, and received $3,455,273 in Medicare payments. The top billing code was J2778 (Injection, ranibizumab, 0.1 mg). Part D data shows 799 prescription claims across 276 beneficiaries totaling $49,302 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 13 records totaling $469. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,943 to $3,455,273. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,850 and ending at $49,302. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2017 Medicare payment: $2,943 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,694 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $30,650 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $26,116 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,036,940 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,404,406 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,828,328 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,455,273 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20171428$2,943
20184196$5,694
2019136588$30,650
202088386$26,116
20211,07110,397$2,036,940
20221,44819,706$3,404,406
20231,74029,472$3,828,328
20241,85249,467$3,455,273

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$25K$51K2015 Drug cost: $3,850 (USD; Tot_Drug_Cst)2016 Drug cost: $7,780 (USD; Tot_Drug_Cst)2017 Drug cost: $40,150 (USD; Tot_Drug_Cst)2018 Drug cost: $2,807 (USD; Tot_Drug_Cst)2019 Drug cost: $4,252 (USD; Tot_Drug_Cst)2020 Drug cost: $6,879 (USD; Tot_Drug_Cst)2021 Drug cost: $5,594 (USD; Tot_Drug_Cst)2022 Drug cost: $4,804 (USD; Tot_Drug_Cst)2023 Drug cost: $50,567 (USD; Tot_Drug_Cst)2024 Drug cost: $49,302 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153371$3,850
201667191$7,780
20172076$40,150
20182467$2,807
20192052$4,252
20203270$6,879
20213874$5,594
20224472$4,804
2023206538$50,567
2024276799$49,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J2778Injection, ranibizumab, 0.1 mg7339,728$123
92004New patient complete exam of visual system407407$112
92014Established patient complete exam of visual system1,3902,298$94
67028Injection of drug into eye9813,004$91
92134Imaging of retina1,6662,931$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium431,479$14,855
Bromfenac SodiumBromfenac Sodium451,885$7,219
Prednisolone AcetatePrednisolone Acetate1064,337$5,309
Brimonidine TartrateBrimonidine Tartrate25013,307$2,634
Loteprednol EtabonateLoteprednol Etabonate11420$1,812

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$469Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amar Patel, MD?

Tedicare shows public-source Medicare data for Amar Patel, MD (NPI 1871882449), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amar Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amar Patel, MD?

Amar Patel, MD is linked to HARSHI BAINS MDPA (billing NPI 1275644049) in the available physician profile data.

Does Amar Patel, MD have Open Payments data?

Amar Patel, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.